Location History:
- Phibsoboro, GB (2001)
- Essex, GB (2012)
Company Filing History:
1 out of 1 
1 out of 160 Years Active: 2001-2012
Title: The Innovative Contributions of Kenneth Iain Cumming
Introduction
Kenneth Iain Cumming is a notable inventor based in Essex, GB. He has made significant contributions to the field of pharmaceutical formulations, holding a total of 2 patents. His work focuses on developing innovative solutions that enhance the delivery and effectiveness of active ingredients in medications.
Latest Patents
Cumming's latest patents include "Controlled-release nanoparticulate compositions" and "Rapidly disintegrating solid oral dosage form." The first patent describes controlled release nanoparticulate formulations that comprise a nanoparticulate agent and a rate-controlling polymer. This formulation is designed to prolong the release of the agent for a time period ranging from about 2 to about 24 hours or longer. The second patent discloses a rapidly disintegrating solid oral dosage form that includes a poorly soluble active ingredient and at least one pharmaceutically acceptable water-soluble or water-dispersible excipient. This dosage form combines rapid presentation and rapid dissolution of the active ingredient in the oral cavity.
Career Highlights
Throughout his career, Kenneth Iain Cumming has worked with several prominent companies, including Flak Pharma International Ltd. and Alkermes Pharma Ireland Limited. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the development of effective drug delivery systems.
Collaborations
Cumming has collaborated with notable professionals in the field, including Rajeev A Jain and Maurice Joseph Anthony Clancy. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Kenneth Iain Cumming's contributions to pharmaceutical innovations through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to influence the development of effective drug delivery systems, showcasing the importance of innovation in healthcare.